Literature DB >> 15345228

Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice.

Camila Indiani de Oliveira1, Maria Jania Teixeira, Clarissa Romero Teixeira, Joílson Ramos de Jesus, Andréa Bomura Rosato, João Santa da Silva, Cláudia Brodskyn, Manoel Barral-Netto, Aldina Barral.   

Abstract

Leishmania braziliensis is the species responsible for the majority of cases of human cutaneous leishmaniasis in Brazil. In the present study, L. braziliensis isolates from two different geographic areas in Brazil were studied by RAPD, using arbitrary primers. We also evaluated other biological features of these two isolates. We compared (a) the clinical features they initiate or not once delivered subcutaneously as stationary-phase promastigotes in the footpad of BALB/c mice; (b) the parasite load in both the footpad and the draining lymph node; (c) the cytokines present in the supernatant of cultures of the cell suspensions from the draining lymph nodes; and (d) the cell types present at the site of parasite delivery. The results show that the L. braziliensis strain from Ceará (H3227) is genotypically different from the L. braziliensis strain from Bahia (BA788). H3227-parasitized mice developed detectable lesions, whereas BA788-parasitized mice did not. Fifteen days post parasite inoculation there was an increase in the numbers of macrophages and lymphocytes in the footpads, whatever the parasite inoculum. Parasite load at the inoculation site--namely the footpad--did not differ significantly; in draining lymph nodes, however, it increased over the period under study. Early after parasite inoculation, the cells recovered from the draining lymph nodes of BA788-parasitized mice produced higher levels of IFN-gamma, a feature coupled to a higher number of NK cells. Later, after the parasite inoculation, there was an increased content of IL-12p70 and IL-10 in the supernatant of cells recovered from the lymph nodes of H3227-parasitized mice. This comparative analysis points out that L. braziliensis isolates differing in their genomic profiles do establish different parasitic processes in BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345228     DOI: 10.1016/j.micinf.2004.05.009

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  17 in total

1.  Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fernanda O Novais; Fabiano Oliveira; Jorge Clarêncio; Almério Noronha; Aldina Barral; Claudia Brodskyn; Camila I de Oliveira
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Authors:  Tiffany Weinkopff; Anita Mariotto; Gregoire Simon; Yazmin Hauyon-La Torre; Floriane Auderset; Steffen Schuster; Haroun Zangger; Nicolas Fasel; Aldina Barral; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

3.  Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns.

Authors:  Maria Jania Teixeira; Juliana Dumet Fernandes; Clarissa Romero Teixeira; Bruno Bezerril Andrade; Margarida Lima Pompeu; João Santana da Silva; Cláudia Ida Brodskyn; Manoel Barral-Netto; Aldina Barral
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.

Authors:  F Janaina Soares Rocha; Ulrike Schleicher; Jochen Mattner; Gottfried Alber; Christian Bogdan
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

5.  BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production.

Authors:  Diego L Costa; Vanessa Carregaro; Djalma S Lima-Júnior; Neide M Silva; Cristiane M Milanezi; Cristina R Cardoso; Ângela Giudice; Amélia R de Jesus; Edgar M Carvalho; Roque P Almeida; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2011-03-01

6.  Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia.

Authors:  Natalia M Tavares; Robson A Silva; Dirceu J Costa; Maiana A Pitombo; Kiyoshi F Fukutani; José C Miranda; Jesus G Valenzuela; Aldina Barral; Camila I de Oliveira; Manoel Barral-Netto; Claudia Brodskyn
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

7.  The immunobiology of Leishmania braziliensis infection.

Authors:  Camila I de Oliveira; Claudia I Brodskyn
Journal:  Front Immunol       Date:  2012-06-08       Impact factor: 7.561

8.  Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally.

Authors:  Cintia F de Araújo; Virgínia M G Silva; Andre Cronemberger-Andrade; Luciana S Aragão-França; Viviane C J Rocha; Priscila S L Santos; Lain Pontes-de-Carvalho
Journal:  BMC Res Notes       Date:  2014-02-01

9.  Ecto-nucleotidase activities of promastigotes from Leishmania (Viannia) braziliensis relates to parasite infectivity and disease clinical outcome.

Authors:  Pauline M Leite; Rodrigo S Gomes; Amanda B Figueiredo; Tiago D Serafim; Wagner L Tafuri; Carolina C de Souza; Sandra A L Moura; Juliana L R Fietto; Maria N Melo; Fátima Ribeiro-Dias; Milton A P Oliveira; Ana Rabello; Luís C C Afonso
Journal:  PLoS Negl Trop Dis       Date:  2012-10-11

10.  Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping.

Authors:  João Paulo C de Oliveira; Flora Fernandes; Angela K Cruz; Viviane Trombela; Elisângela Monteiro; Anamaria A Camargo; Aldina Barral; Camila I de Oliveira
Journal:  Kinetoplastid Biol Dis       Date:  2007-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.